Literature DB >> 12503543

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Michel E Bertrand1, Maarten L Simoons, Keith A A Fox, Lars C Wallentin, Christian W Hamm, Eugene McFadden, Pim J De Feyter, Giuseppe Specchia, Witold Ruzyllo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12503543     DOI： 10.1053/euhj.2002.3385

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  116 in total

Review 1.  Transport and centralization of acute coronary syndrome care.

Authors:  James L Orford; Peter B Berger
Journal:  Curr Cardiol Rep       Date:  2004-07       Impact factor: 2.931

Review 2.  Management of acute coronary syndromes: an update.

Authors:  Keith A A Fox
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

3.  Practising what is preached: the MINAP study.

Authors:  O C Raffel; H D White
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 4.  Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes.

Authors:  Peter R Sinnaeve
Journal:  J Cardiovasc Transl Res       Date:  2011-11-01       Impact factor: 4.132

5.  The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.

Authors:  Christopher J Boos; Balu Balakrishnan; Gregory Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2007-06-16       Impact factor: 2.300

Review 6.  Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes.

Authors:  Nick Bosanquet; Bengt Jönsson; Keith A A Fox
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Is nighttime blood pressure important in cardiovascular risk assessment in coronary atherosclerosis?

Authors:  W Sobiczewski; M Wirtwein; M Gruchala
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 8.  Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.

Authors:  S J Walsh; M S Spence; D Crossman; A A J Adgey
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

9.  Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention.

Authors:  Y L Gu; T Svilaas; I C C van der Horst; F Zijlstra
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

10.  A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans.

Authors:  Joseph A Jakubowski; Nobuko Matsushima; Fumitoshi Asai; Hideo Naganuma; John T Brandt; Takashi Hirota; Stephen Freestone; Kenneth J Winters
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.